Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI

Journal of the American Society of Nephrology

Volumn 28, Issue 1, 2017, Pages 218-229

  Martin Sanchez, Diego ^a   Ruiz Andres, Olga ^a   Poveda, Jonay ^a,b   Carrasco, Susana ^a,b   Cannata Ortiz, Pablo ^c   Sanchez Niño, Maria D ^a,b   Ruiz Ortega, Marta ^a,b,d   Egido, Jesus ^a,d,e   Linkermann, Andreas ^f   Ortiz, Alberto ^a,b,d,e   Sanz, Ana B ^a,b,g  

^a Red de Investigacion Renal   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^c AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^d Grupo de Estudios Peritoneales de Madrid de REDinREN   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f UNIVERSITY OF KIEL   (Germany)

^g UAM)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CHONDROITIN SULFATE IRON; CREATININE; FERROSTATIN 1; FOLIC ACID; INTERLEUKIN 10; INTERLEUKIN 33; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITROGEN; PROTEIN KINASE; RECEPTOR INTERACTING PROTEIN KINASE 3; UNCLASSIFIED DRUG; UREA; IRON;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FERROPTOSIS; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; LIPID PEROXIDATION; MOUSE; NECROPTOSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUNEL ASSAY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; NECROSIS; PATHOLOGY; PHYSIOLOGY;

ACUTE KIDNEY INJURY; ANIMALS; CELL DEATH; FOLIC ACID; IRON; MICE; MICE, INBRED C57BL; NECROSIS;

EID: 85021850413     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015121376     Document Type: Article

References (37)

1. Bellomo R, Kellum JA, Ronco C: Acute kidney injury. Lancet 380: 756-766, 2012
2. Siew ED, Parr SK, Abdel-Kader K, Eden SK, Peterson JF, Bansal N, Hung AM, Fly J, Speroff T, Ikizler TA, Matheny ME: Predictors of recurrent AKI. J Am Soc Nephrol 27: 1190-1200, 2016
3. Linkermann A, Stockwell BR, Krautwald S, Anders HJ: Regulated cell death and inflammation: An auto-amplification loop causes organ failure. Nat Rev Immunol 14: 759-767, 2014
4. Linkermann A, Green DR: Necroptosis. N Engl J Med 370: 455-465, 2014
5. + T cells. Science 350: 328-334, 2015
6. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK: Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137: 1112-1123, 2009
7. Wu XN, Yang ZH, Wang XK, Zhang Y, Wan H, Song Y, Chen X, Shao J, Han J: Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homointeraction in mediating necroptosis. Cell Death Differ 21: 1709-1720, 2014
8. Sun L, Wang H, Wang Z, He S, Chen S, Liao D, Wang L, Yan J, Liu W, Lei X, Wang X:Mixed lineage kinase domain-like proteinmediates necrosis signaling downstream of RIP3 kinase. Cell 148: 213-227, 2012
9. Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz PS, Weinlich R, Vanden Berghe T, Vandenabeele P, Pasparakis M, Bleich M, Weinberg JM, Reichel CA, Bräsen JH, Kunzendorf U, Anders HJ, Stockwell BR, Green DR, Krautwald S: Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A 111: 16836-16841, 2014
10. Linkermann A, Bräsen JH, Darding M, Jin MK, Sanz AB, Heller JO, De Zen F, Weinlich R, Ortiz A, Walczak H, Weinberg JM, Green DR, Kunzendorf U, Krautwald S: Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A 110: 12024-12029, 2013
11. Xu Y, Ma H, Shao J, Wu J, Zhou L, Zhang Z, Wang Y, Huang Z, Ren J, Liu S, Chen X, Han J: A role for tubular necroptosis in cisplatin-induced AKI. J Am Soc Nephrol 26: 2647-2658, 2015
12. Tristão VR, Pessoa EA, Nakamichi R, Reis LA, Batista MC, Durão Junior MS, Monte JC: Synergistic effect of apoptosis and necroptosis inhibitors in cisplatin-induced nephrotoxicity. Apoptosis 21: 51-59, 2016
13. Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, Brown LM, Girotti AW, Cornish VW, Schreiber SL, Stockwell BR: Regulation of ferroptotic cancer cell death by GPX4. Cell 156: 317-331, 2014
14. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149: 1060-1072, 2012
15. Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, Basavarajappa D, Radmark O, Kobayashi S, Seibt T, Beck H, Neff F, Esposito I, Wanke R, Förster H, Yefremova O, Heinrichmeyer M, Bornkamm GW, Geissler EK, Thomas SB, Stockwell BR, O'Donnell VB, Kagan VE, Schick JA, Conrad M: Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16: 1180-1191, 2014
16. Skouta R, Dixon SJ, Wang J, Dunn DE, Orman M, Shimada K, Rosenberg PA, Lo DC, Weinberg JM, Linkermann A, Stockwell BR: Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc 136: 4551-4556, 2014
17. Metz-Kurschel U, Kurschel E, Wagner K, Aulbert E, Graben N, Philipp T: Folate nephropathy occurring during cytotoxic chemotherapy with high-dose folinic acid and 5-fluorouracil. Ren Fail 12: 93-97, 1990
18. Gupta A, Puri V, Sharma R, Puri S: Folic acid induces acute renal failure (ARF) by enhancing renal prooxidant state. Exp Toxicol Pathol 64: 225-232, 2012
19. Akcay A, Nguyen Q, He Z, Turkmen K, Won Lee D, Hernando AA, Altmann C, Toker A, Pacic A, Ljubanovic DG, Jani A, Faubel S, Edelstein CL: IL-33 exacerbates acute kidney injury. J AmSocNephrol 22: 2057-2067, 2011
20. Thierry A, Giraud S, Robin A, Barra A, Bridoux F, Ameteau V, Hauet T, Girard JP, Touchard G, Gombert JM, Herbelin A: The alarmin concept applied to human renal transplantation: Evidence for a differential implication of HMGB1 and IL-33. PLoS One 9: e88742, 2014
21. Sanz AB, Izquierdo MC, Sanchez-Niño MD, Ucero AC, Egido J, Ruiz- Ortega M, Ramos AM, Putterman C, Ortiz A: TWEAK and the progression of renal disease: Clinical translation. Nephrol Dial Transplant 29[Suppl 1]: i54-i62, 2014
22. Moreno JA, Izquierdo MC, Sanchez-Niño MD, Suárez-Alvarez B, Lopez- Larrea C, Jakubowski A, Blanco J, Ramirez R, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A, Sanz AB: The inflammatory cytokines TWEAK and TNFa reduce renal klotho expression throughNFkB. J AmSocNephrol 22: 1315-1325, 2011
23. Upton JW, Kaiser WJ, Mocarski ES: Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 7: 302-313, 2010
24. Linkermann A, Bräsen JH, Himmerkus N, Liu S, Huber TB, Kunzendorf U, Krautwald S: Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury. Kidney Int 81: 751-761, 2012
25. Homsi E, Andreazzi DD, Faria JB, Janino P: TNF-α-mediated cardiorenal injury after rhabdomyolysis in rats. Am J Physiol Renal Physiol 308: F1259-F1267, 2015
26. Linkermann A, Heller JO, Prókai A, Weinberg JM, De Zen F, Himmerkus N, Szabó AJ, Bräsen JH, Kunzendorf U, Krautwald S: The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice. J Am Soc Nephrol 24: 1545-1557, 2013
27. Mulay SR, Desai J, Kumar SV, Eberhard JN, Thomasova D, Romoli S, Grigorescu M, Kulkarni OP, Popper B, Vielhauer V, Zuchtriegel G, Reichel C, Bräsen JH, Romagnani P, Bilyy R, Munoz LE, Herrmann M, Liapis H, Krautwald S, Linkermann A, Anders HJ: Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun 7: 10274, 2016
28. Mulay SR, Linkermann A, Anders HJ: Necroinflammation in Kidney Disease. J Am Soc Nephrol 27: 27-39, 2016
29. Kaczmarek A, Vandenabeele P, Krysko DV: Necroptosis: The release of damage-associated molecular patterns and its physiological relevance. Immunity 38: 209-223, 2013
30. Lefrançais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C: IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 109: 1673-1678, 2012
31. Rickard JA, O'Donnell JA, Evans JM, Lalaoui N, Poh AR, Rogers T, Vince JE, Lawlor KE, Ninnis RL, Anderton H, Hall C, Spall SK, Phesse TJ, Abud HE, Cengia LH, Corbin J, Mifsud S, Di Rago L, Metcalf D, Ernst M, Dewson G, Roberts AW, Alexander WS, Murphy JM, Ekert PG, Masters SL, Vaux DL, Croker BA, Gerlic M, Silke J: RIPK1 regulates RIPK3-MLKLdriven systemic inflammation and emergency hematopoiesis. Cell 157: 1175-1188, 2014
32. Moriwaki K, Balaji S, McQuade T, Malhotra N, Kang J, Chan FK: The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair. Immunity 41: 567-578, 2014
33. Bullock AN, Degterev A: Targeting RIPK1, 2, 3 to combat inflammation. Oncotarget 6: 34057-34058, 2015
34. Pomeshchik Y, Kidin I, Korhonen P, Savchenko E, Jaronen M, Lehtonen S, Wojciechowski S, Kanninen K, Koistinaho J, Malm T: Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury. Brain Behav Immun 44: 68-81, 2015
35. Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D: TSLP elicits IL- 33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5: 170ra16, 2013
36. Sanz AB, Justo P, Sanchez-Niño MD, Blanco-Colio LM, Winkles JA, Kreztler M, Jakubowski A, Blanco J, Egido J, Ruiz-Ortega M, Ortiz A: The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19: 695-703, 2008
37. Newton K, Sun X, Dixit VM: Kinase RIP3 is dispensable for normal NFkappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol Cell Biol 24: 1464-1469, 2004